Date published: 2025-11-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Antxrl Inhibitors

Antxrl Inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of the Antxrl protein, which is part of the anthrax toxin receptor family. Antxrl, also known as Anthrax Receptor-Like, plays a crucial role in cellular processes by mediating interactions with various extracellular ligands, including toxins and other signaling molecules. The protein is involved in facilitating the entry of certain toxins into cells, where they can exert their effects by disrupting cellular functions. Antxrl Inhibitors function by binding to key regions of the Antxrl protein, such as the extracellular ligand-binding domain or the transmembrane domain, thereby blocking its ability to interact with its ligands. This inhibition prevents the receptor from initiating the internalization of ligands, effectively disrupting the downstream signaling pathways that depend on these interactions.

The chemical design and properties of Antxrl Inhibitors are crucial for their specificity and effectiveness. These inhibitors are typically engineered to fit precisely within the ligand-binding site of the Antxrl protein, mimicking the natural ligands to competitively block their binding. The inhibitors may include hydrophobic regions that interact with the non-polar pockets of the receptor and polar or charged groups that form hydrogen bonds or electrostatic interactions with key amino acid residues in the binding site. Additionally, some inhibitors may target other critical regions of Antxrl, such as the transmembrane domain, to disrupt the receptor's conformation or its ability to anchor within the cell membrane. The solubility, stability, and bioavailability of these inhibitors are optimized to ensure that they can effectively reach and inhibit Antxrl in the cellular environment. The kinetics of binding, including how quickly the inhibitor associates with and dissociates from the Antxrl protein, are also important factors that influence the overall potency and duration of the inhibition. Understanding the interactions between Antxrl Inhibitors and their target protein provides valuable insights into the molecular mechanisms of ligand-receptor interactions and the broader biological processes mediated by the Antxrl protein. This understanding is essential for elucidating how Antxrl contributes to cellular responses to external signals and how its inhibition can alter these processes.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$92.00
$204.00
19
(1)

Inhibits the Hedgehog (Hh) signaling pathway which is crucial for cell growth and differentiation. ANTXR like protein may be regulated by pathways that are influenced by Hedgehog signaling, thereby inhibition of this pathway can lead to a decrease in ANTXR like activity by limiting its regulatory inputs.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Inhibits the mTOR pathway which is involved in cell growth, proliferation, and survival. As ANTXR like protein may require mTOR signaling for these cellular processes, inhibition by Rapamycin would suppress ANTXR like protein-associated functions.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

Inhibits Rho-associated protein kinase (ROCK), which could alter cytoskeletal dynamics and potentially impact the trafficking or membrane presentation of the ANTXR like protein, thus inhibiting its functional activity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

Selectively inhibits MEK, which is part of the MAPK/ERK pathway involved in cell differentiation and proliferation. Inhibition of this pathway may reduce the functional activity of ANTXR like protein by preventing necessary phosphorylation events.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

Inhibits p38 MAP kinase, which may influence inflammatory response and stress-activated pathways that could affect the activity of ANTXR like protein by altering its cellular context or activation state.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Inhibits PI3K, which is upstream of many growth and survival signaling pathways. ANTXR like protein function could be inhibited by the resultant decrease in cellular survival signals.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, which is implicated in stress responses and apoptosis. Inhibiting JNK could diminish the functional activity of ANTXR like protein by impacting the stress response mechanisms that regulate its activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

Inhibits MEK1/2 in the MAPK/ERK pathway, potentially reducing the functional activity of ANTXR like protein by limiting cell proliferation and differentiation signals that may be necessary for its activity.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$150.00
$349.00
15
(1)

Inhibits Aurora kinase, which is involved in mitotic progression. Inhibiting this kinase could potentially decrease the activity of ANTXR like protein by disrupting cell cycle progression that is necessary for its function.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Inhibits PI3K, leading to a decrease in AKT signaling and potentially inhibiting the activity of ANTXR like protein by restricting survival and growth signals.